Citadel Advisors’s Caribou Biosciences CRBU Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $303K | Buy |
+240,219
| New | +$303K | ﹤0.01% | 4609 |
|
|
2025
Q1 | – | Hold |
0
| – | – | – | 6081 |
|
|
2024
Q4 | – | Sell |
-64,458
| Closed | -$126K | – | 6098 |
|
|
2024
Q3 | $126K | Buy |
64,458
+1,968
| +3% | +$3.86K | ﹤0.01% | 4825 |
|
|
2024
Q2 | $102K | Sell |
62,490
-464,424
| -88% | -$762K | ﹤0.01% | 4940 |
|
|
2024
Q1 | $2.71M | Buy |
+526,914
| New | +$2.71M | ﹤0.01% | 2240 |
|
|
2023
Q4 | – | Sell |
-2,989
| Closed | -$14.3K | – | 5981 |
|
|
2023
Q3 | $14.3K | Buy |
2,989
+868
| +41% | +$4.15K | ﹤0.01% | 5381 |
|
|
2023
Q2 | $9.01K | Sell |
2,121
-280,729
| -99% | -$1.19M | ﹤0.01% | 5390 |
|
|
2023
Q1 | $1.5M | Buy |
282,850
+244,955
| +646% | +$1.3M | ﹤0.01% | 2788 |
|
|
2022
Q4 | $238K | Buy |
37,895
+9,964
| +36% | +$62.6K | ﹤0.01% | 4540 |
|
|
2022
Q3 | $295K | Sell |
27,931
-38,044
| -58% | -$402K | ﹤0.01% | 4555 |
|
|
2022
Q2 | $358K | Sell |
65,975
-291,526
| -82% | -$1.58M | ﹤0.01% | 4464 |
|
|
2022
Q1 | $3.28M | Buy |
357,501
+206,391
| +137% | +$1.89M | ﹤0.01% | 2467 |
|
|
2021
Q4 | $2.28M | Buy |
+151,110
| New | +$2.28M | ﹤0.01% | 2918 |
|